Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory™ for CAR-T therapy manufacturing

Astraveus France

Agreement with Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) for the manufacturing of CAR-T therapies using Lakhesys Benchtop Cell Factory™Partnership to demonstrate the ability of Astraveus' technology to deliver reduced costs and increased efficiency in CAR-T manufacturingView original content:https://www.prnewswire.co.uk/news-releases/astraveus-enters-strategic-partnership-with-necstgen-to-evaluate-lakhesys-benchtop-cell-factory-for-car-t-therapy-manufacturing-302445183.html